Talk to More Primary Prevention Patients About the Benefits and Risks of Statins

More patients will take statins for PRIMARY prevention of CV disease.

We know statins improve outcomes for SECONDARY prevention. But what about patients who DON'T have CV disease?

Up until now, evidence has been murkier...especially in nonwhites.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote